Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | taurine | 60 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 61 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 62 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 63 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 64 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 64 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 68 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 73 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 73 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 73 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 74 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 74 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 74 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 74 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 75 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 75 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 76 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 76 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 76 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 77 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 77 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 80 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 80 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 82 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 82 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 83 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 84 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 86 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 86 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 87 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 87 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 88 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 89 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 91 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 91 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 92 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 93 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 93 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 96 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 96 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 99 | Counts | 60-64 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 100 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 101 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 101 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 101 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 102 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 103 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 104 | Counts | 50-54 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 104 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 105 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 106 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 109 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 110 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 111 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 111 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 112 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 112 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 113 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 114 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 115 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 115 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 119 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 121 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 123 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 123 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 123 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 124 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 125 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 131 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 132 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 134 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 137 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 143 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 146 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 149 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 166 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 167 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 1132 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 1909 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 2170 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 2328 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 2428 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 2463 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 2497 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 2512 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 2568 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 2594 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 2837 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 2841 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 2845 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 2930 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 2945 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3000 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3019 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3024 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 3076 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3205 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 3205 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3306 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3322 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3348 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 3359 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3388 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3415 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3480 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 3486 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 3511 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3570 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3584 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3633 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3660 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 3750 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3795 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 3840 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3845 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 3861 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 3907 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 3924 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 3929 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 3932 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 3938 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3944 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 3955 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4028 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 4038 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4106 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4114 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4123 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 4125 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4129 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4179 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4182 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4228 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4248 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 4261 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4272 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4342 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 4364 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4381 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4381 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4500 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4506 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4506 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4635 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 4679 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4687 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4687 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4707 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4732 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 4750 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 4760 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4824 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4833 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 4882 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 4887 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 4911 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4924 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 4931 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 4987 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 5004 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 5014 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 5050 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5054 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | taurine | 5120 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5137 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 5207 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5275 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5328 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 5379 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5394 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5406 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5409 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5413 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 5445 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5464 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5514 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5548 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5573 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 5573 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5602 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5624 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 5652 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 5663 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5679 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | taurine | 5698 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5759 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 5774 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | taurine | 5788 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | taurine | 5820 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 5873 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5904 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | taurine | 5915 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | taurine | 5962 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 5980 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | taurine | 6052 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 6063 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 6078 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 6098 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | taurine | 6118 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | taurine | 6154 | Counts | 65-69 | Female | Former | Adenocarcinoma |
Return to search page